Page last updated: 2024-10-18

glycine and Prostatic Neoplasms, Castration-Resistant

glycine has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adler, D1
Menon, R1
Braun, M1
Offermann, A1
Queisser, A1
Boehm, D1
Vogel, W1
Rüenauver, K1
Ruiz, C1
Zellweger, T1
Svensson, M1
Andren, O1
Kristiansen, G1
Wernert, N1
Bubendorf, L1
Kirfel, J1
Biskup, S1
Perner, S1
Wei, X1
Zhou, P1
Lin, X1
Lin, Y1
Wu, S1
Diao, P1
Xie, H1
Xie, K1
Tang, P1

Other Studies

2 other studies available for glycine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.
    International journal of cancer, 2014, 07-01, Volume: 135, Issue:1

    Topics: Aged; Androgens; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glyci

2014
MLN2238 synergizes BH3 mimetic ABT-263 in castration-resistant prostate cancer cells by induction of NOXA.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:10

    Topics: Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; BH3 Interacting Domain

2014